Literature DB >> 10921980

Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR.

J S Moncrief1, L Zheng, L M Neville, D M Lyerly.   

Abstract

Toxin-specific enzyme immunoassays, cytotoxicity assays, and PCR were used to analyze 48 toxin A-negative, toxin B-positive Clostridium difficile isolates from various geographical sites around the world. All the isolates were negative by the TOX-A TEST and positive by the TOX A/B TEST. A deletion of approximately 1.7 kb was found at the 3' end of the toxA gene for all the isolates, similar to the deletion in toxinotype VIII strains (e.g., C. difficile serotype F 1470). Additional PCR analysis indicated that the toxin B encoded by these isolates contains sequence variations downstream of the active site compared to the sequence of reference strain VPI 10463. This variation may extend the glucosylation spectrum to Ras proteins, as observed previously for closely related lethal toxin from Clostridium sordellii and toxin B from toxin A-negative, toxin B-positive strain F 1470. Toxin A-negative, toxin B-positive isolates have recently been associated with disease in humans, and they may be more common than was previously supposed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10921980      PMCID: PMC87187     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  26 in total

1.  A novel cytotoxin from Clostridium difficile serogroup F is a functional hybrid between two other large clostridial cytotoxins.

Authors:  E Chaves-Olarte; P Löw; E Freer; T Norlin; M Weidmann; C von Eichel-Streiber; M Thelestam
Journal:  J Biol Chem       Date:  1999-04-16       Impact factor: 5.157

2.  The toxigenic element of Clostridium difficile strain VPI 10463.

Authors:  G A Hammond; J L Johnson
Journal:  Microb Pathog       Date:  1995-10       Impact factor: 3.738

3.  Chimeric clostridial cytotoxins: identification of the N-terminal region involved in protein substrate recognition.

Authors:  F Hofmann; C Busch; K Aktories
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

4.  Characterization of polymorphisms in the toxin A and B genes of Clostridium difficile.

Authors:  M Rupnik; V Braun; F Soehn; M Janc; M Hofstetter; R Laufenberg-Feldmann; C von Eichel-Streiber
Journal:  FEMS Microbiol Lett       Date:  1997-03-15       Impact factor: 2.742

5.  Localization of the glucosyltransferase activity of Clostridium difficile toxin B to the N-terminal part of the holotoxin.

Authors:  F Hofmann; C Busch; U Prepens; I Just; K Aktories
Journal:  J Biol Chem       Date:  1997-04-25       Impact factor: 5.157

6.  The ras-related protein Ral is monoglucosylated by Clostridium sordellii lethal toxin.

Authors:  F Hofmann; G Rex; K Aktories; I Just
Journal:  Biochem Biophys Res Commun       Date:  1996-10-03       Impact factor: 3.575

7.  A common motif of eukaryotic glycosyltransferases is essential for the enzyme activity of large clostridial cytotoxins.

Authors:  C Busch; F Hofmann; J Selzer; S Munro; D Jeckel; K Aktories
Journal:  J Biol Chem       Date:  1998-07-31       Impact factor: 5.157

8.  A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates.

Authors:  M Rupnik; V Avesani; M Janc; C von Eichel-Streiber; M Delmée
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

9.  Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR.

Authors:  H Kato; N Kato; K Watanabe; N Iwai; H Nakamura; T Yamamoto; K Suzuki; S M Kim; Y Chong; E B Wasito
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

10.  Effects of Clostridium difficile toxins given intragastrically to animals.

Authors:  D M Lyerly; K E Saum; D K MacDonald; T D Wilkins
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

View more
  14 in total

Review 1.  Clostridium difficile testing: after 20 years, still challenging.

Authors:  Tracy D Wilkins; David M Lyerly
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 2.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

3.  International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants.

Authors:  Stuart Johnson; Susan P Sambol; Jon S Brazier; Michel Delmée; V Avesani; Michelle M Merrigan; Dale N Gerding
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

4.  New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia.

Authors:  Maja Rupnik; Naoki Kato; Miklavz Grabnar; Haru Kato
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

5.  Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France.

Authors:  Frédéric Barbut; Valérie Lalande; Béatrice Burghoffer; Huong Vu Thien; Emmanuel Grimprel; Jean-Claude Petit
Journal:  J Clin Microbiol       Date:  2002-06       Impact factor: 5.948

6.  U.S.-Based National Surveillance for Fidaxomicin Susceptibility of Clostridioides difficile-Associated Diarrheal Isolates from 2013 to 2016.

Authors:  C M Thorpe; L A McDermott; M K Tran; J Chang; S G Jenkins; E J C Goldstein; R Patel; B A Forbes; S Johnson; D N Gerding; D R Snydman
Journal:  Antimicrob Agents Chemother       Date:  2019-06-24       Impact factor: 5.191

7.  Evidence that Clostridium difficile TcdC is a membrane-associated protein.

Authors:  Revathi Govind; Govindsamy Vediyappan; Rial D Rolfe; Joe A Fralick
Journal:  J Bacteriol       Date:  2006-05       Impact factor: 3.490

8.  Rapid detection of Clostridium difficile in feces by real-time PCR.

Authors:  Simon D Bélanger; Maurice Boissinot; Natalie Clairoux; François J Picard; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile.

Authors:  Ann M Larson; Angela M Fung; Ferric C Fang
Journal:  J Clin Microbiol       Date:  2009-11-18       Impact factor: 5.948

10.  U.S.-Based National Sentinel Surveillance Study for the Epidemiology of Clostridium difficile-Associated Diarrheal Isolates and Their Susceptibility to Fidaxomicin.

Authors:  D R Snydman; L A McDermott; N V Jacobus; C Thorpe; S Stone; S G Jenkins; E J C Goldstein; R Patel; B A Forbes; S Mirrett; S Johnson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2015-08-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.